Literature DB >> 445355

Treatment of advanced gastrointestinal cancer with 5-fluorouracil and mitomycin C.

S Krauss, T Sonoda, A Solomon.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 445355     DOI： 10.1002/1097-0142(197905)43:5<1598::aid-cncr2820430505>3.0.co;2-y

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  10 in total

1.  Clotting activation after blood transfusion in patients receiving 5-fluorouracil and mitomycin-C treatment.

Authors:  G Agnelli; P Gresele; G G Nenci
Journal:  Cancer Chemother Pharmacol       Date:  1981       Impact factor: 3.333

2.  Chemotherapy in pancreatic cancer: results of a controlled, prospective, randomised, multicentre trial.

Authors:  C N Mallinson; M O Rake; J B Cocking; C A Fox; M T Cwynarski; B L Diffey; G A Jackson; J Hanley; V J Wass
Journal:  Br Med J       Date:  1980-12-13

3.  Update in cancer chemotherapy: gastrointestinal cancer--colorectal cancer, Part 2.

Authors:  J C Wright
Journal:  J Natl Med Assoc       Date:  1986-05       Impact factor: 1.798

4.  Acute leukemia: an association with atypical hemolytic uremic syndrome.

Authors:  Hyewon Hahn; Il Soo Ha; Hyoung Soo Choi; Hee Young Shin; Hae Il Cheong; Hyo Seop Ahn; Yong Choi
Journal:  Pediatr Nephrol       Date:  2003-05-16       Impact factor: 3.714

5.  Mitomycin-induced hemolytic uremic kidney. An experimental model in the rat.

Authors:  V Cattell
Journal:  Am J Pathol       Date:  1985-10       Impact factor: 4.307

6.  Severe glomerular mesangiolysis in a patient with rectal adenocarcinoma treated with cytotoxic drugs.

Authors:  G Mazzucco; G Fornari; G Monga
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1982

7.  Mitomycin-C plus metronidazole in advanced carcinoma of the breast.

Authors:  D J Stewart; J A Maroun; B Lefebvre; R Heringer; A F Crook
Journal:  Breast Cancer Res Treat       Date:  1985       Impact factor: 4.872

8.  Haemolytic-uraemic syndrome complicating long-term mitomycin C and 5-fluorouracil therapy for gastric carcinoma.

Authors:  J Crocker; E L Jones
Journal:  J Clin Pathol       Date:  1983-01       Impact factor: 3.411

9.  5-Fluorouracil (FU) and mitomycin C (MMC) in the management of colorectal carcinoma. Part II. In vitro activity of the two drugs in short-term tumor cultures.

Authors:  F Franchi; C Barone; P Seminara; G Codacci-Pisanelli; M Codacci-Pisanelli; G M Ferri; C Garufi; A Grieco; V Pagani
Journal:  Med Oncol Tumor Pharmacother       Date:  1991

10.  Phase I study of everolimus and mitomycin C for patients with metastatic esophagogastric adenocarcinoma.

Authors:  Dominique Werner; Akin Atmaca; Claudia Pauligk; Anette Pustowka; Elke Jäger; Salah-Eddin Al-Batran
Journal:  Cancer Med       Date:  2013-04-02       Impact factor: 4.452
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.